These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 16030043)
1. FGF-23, vitamin D and calcification: the unholy triad. Razzaque MS; St-Arnaud R; Taguchi T; Lanske B Nephrol Dial Transplant; 2005 Oct; 20(10):2032-5. PubMed ID: 16030043 [No Abstract] [Full Text] [Related]
2. Correlation among hyperphosphatemia, type II sodium phosphate transporter activity, and vitamin D metabolism in Fgf-23 null mice. Sitara D Ann N Y Acad Sci; 2007 Nov; 1116():485-93. PubMed ID: 17646263 [TBL] [Abstract][Full Text] [Related]
3. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Hesse M; Fröhlich LF; Zeitz U; Lanske B; Erben RG Matrix Biol; 2007 Mar; 26(2):75-84. PubMed ID: 17123805 [TBL] [Abstract][Full Text] [Related]
4. Endocrine fibroblast growth factors as regulators of metabolic homeostasis. Kurosu H; Kuro-O M Biofactors; 2009; 35(1):52-60. PubMed ID: 19319846 [TBL] [Abstract][Full Text] [Related]
5. [Regulatory effect of FGF23 on phosphate and vitamin D metabolism]. Yamashita T Nihon Rinsho; 2005 Oct; 63 Suppl 10():519-22. PubMed ID: 16279693 [No Abstract] [Full Text] [Related]
7. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Kurosu H; Kuro-O M Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940 [TBL] [Abstract][Full Text] [Related]
9. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. Ichikawa S; Imel EA; Kreiter ML; Yu X; Mackenzie DS; Sorenson AH; Goetz R; Mohammadi M; White KE; Econs MJ J Musculoskelet Neuronal Interact; 2007; 7(4):318-9. PubMed ID: 18094491 [No Abstract] [Full Text] [Related]
10. Fibroblast growth factor 23: roles in health and disease. Imel EA; Econs MJ J Am Soc Nephrol; 2005 Sep; 16(9):2565-75. PubMed ID: 16033853 [No Abstract] [Full Text] [Related]
11. The role of fibroblast growth factor 23 in renal disease. Jonsson KB Nephrol Dial Transplant; 2005 Mar; 20(3):479-82. PubMed ID: 15735238 [No Abstract] [Full Text] [Related]
12. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Kuro-o M Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459 [TBL] [Abstract][Full Text] [Related]
13. Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases. Imanishi Y; Kobayashi K; Kawata T; Inaba M; Nishizawa Y Ther Apher Dial; 2007 Oct; 11 Suppl 1():S32-7. PubMed ID: 17976083 [TBL] [Abstract][Full Text] [Related]
14. Emerging role of a phosphatonin in mineral homeostasis and its derangements. Bielesz B Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396 [TBL] [Abstract][Full Text] [Related]
15. New concepts in pathogenesis of renal hypophosphatemic syndromes. Rastegar A Iran J Kidney Dis; 2009 Jan; 3(1):1-6. PubMed ID: 19377250 [TBL] [Abstract][Full Text] [Related]